James Sidoti
Stock Analyst at Sidoti & Co.
(3.02)
# 1,312
Out of 4,784 analysts
8
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRDX Surmodics | Downgrades: Neutral | $43 | $30.75 | +39.84% | 1 | May 29, 2024 | |
| STAA STAAR Surgical Company | Upgrades: Buy | n/a | $17.79 | - | 2 | Nov 7, 2022 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $0.32 | +1,462.50% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $83.05 | -59.06% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $15.11 | +303.71% | 2 | Jan 21, 2020 |
Surmodics
May 29, 2024
Downgrades: Neutral
Price Target: $43
Current: $30.75
Upside: +39.84%
STAAR Surgical Company
Nov 7, 2022
Upgrades: Buy
Price Target: n/a
Current: $17.79
Upside: -
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $0.32
Upside: +1,462.50%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $83.05
Upside: -59.06%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $15.11
Upside: +303.71%